Phosphodiesterase 3 Inhibitors
"Phosphodiesterase 3 Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that specifically inhibit PHOSPHODIESTERASE 3.
| Descriptor ID |
D058987
|
| MeSH Number(s) |
D27.505.519.389.735.249
|
| Concept/Terms |
Phosphodiesterase 3 Inhibitors- Phosphodiesterase 3 Inhibitors
- Inhibitors, Phosphodiesterase 3
- Phosphodiesterase Type 3 Inhibitors
- PDE-3 Inhibitors
- Inhibitors, PDE-3
- PDE 3 Inhibitors
- PDE3 Inhibitors
- Inhibitors, PDE3
|
Below are MeSH descriptors whose meaning is more general than "Phosphodiesterase 3 Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Phosphodiesterase 3 Inhibitors".
This graph shows the total number of publications written about "Phosphodiesterase 3 Inhibitors" by people in this website by year, and whether "Phosphodiesterase 3 Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2018 | 1 | 1 | 2 |
| 2019 | 1 | 1 | 2 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Phosphodiesterase 3 Inhibitors" by people in Profiles.
-
The Potential Role of Aerosolized Phosphodiesterase 3 Inhibitor Enoximone in the Management of Coronavirus Disease 2019 Hypoxemia: A Case Report. J Aerosol Med Pulm Drug Deliv. 2021 08; 34(4):262-264.
-
PDE3-inhibitor enoximone prevented mechanical ventilation in patients with SARS-CoV-2 pneumonia. Exp Lung Res. 2021 04; 47(3):149-160.
-
Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target. Int Immunopharmacol. 2021 Mar; 92:107336.
-
Ensifentrine (RPL554): an investigational PDE3/4 inhibitor for the treatment of COPD. Expert Opin Investig Drugs. 2019 Oct; 28(10):827-833.
-
Ensifentrine (RPL554): an inhaled 'bifunctional' dual PDE3/4 inhibitor for the treatment of asthma and chronic obstructive pulmonary disease. Pharm Pat Anal. 2018 Nov; 7(6):249-257.
-
Effect of levosimendan on clinical outcomes in adult patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials. Interact Cardiovasc Thorac Surg. 2018 06 01; 26(6):1016-1026.
-
A pathophysiological role of PDE3 in allergic airway inflammation. JCI Insight. 2018 01 25; 3(2).